Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/09/2003CA2478154A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2477751A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003CA2477734A1 Suramin and derivatives thereof as topical microbicide and contraceptive
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350793A1 Medicinal compositions having improved absorbability
10/08/2003EP1350792A1 Medicinal compositions improved in solublity in water
10/08/2003EP1350556A1 Multiple emulsions
10/08/2003EP1350522A1 Topical anesthesia compositions
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350518A1 Prolonged release of GM-CSF
10/08/2003EP1350513A1 Soft gelatine capsule comprising an 17-alpha-estradiol compound and ascorbic acid
10/08/2003EP1350512A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1350508A1 Antifungal formulation and the methods for manufacturing and using the same
10/08/2003EP1350507A1 Delivery of a substance to a pre-determinated site
10/08/2003EP1350434A1 Chewing gum in powder form and method of preparation
10/08/2003EP1349580A1 Process to improve stability of a pharmaceutical composition
10/08/2003EP1349565A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
10/08/2003EP1349564A2 Regulation of cellproliferation and differentiation using topically applied peptides
10/08/2003EP1349561A2 Local use of essential oils for treating herpes labialis
10/08/2003EP1349556A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
10/08/2003EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
10/08/2003EP1349545A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
10/08/2003EP1349544A2 Adhesive label with fluidifying agents for natural airway secretions
10/08/2003EP1349543A1 Method for producing tablets from plant extracts
10/08/2003EP1349542A1 Amoxycillin pellets
10/08/2003EP1349541A1 Self emulsifying lipid matrix (selm)
10/08/2003EP1349540A2 Topical alcoholic solution of a salicylic acid derivative and acemannan
10/08/2003EP1349533A2 Propellant-gas-free spray preparations
10/08/2003EP1349531A1 Spaced drug delivery system
10/08/2003EP1253913B1 Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1165056B1 A process for the microencapsulation of medicaments
10/08/2003EP1150935B1 Method and apparatus for shaping particles by ultrasonic cavitation
10/08/2003EP1140018B1 Polyol/oil suspensions for the sustained release of proteins
10/08/2003EP1137398B1 Pharmaceutical preparation for inhalation of an opioid
10/08/2003EP0994884B1 Diphosphonic acid salts for the treatment of osteoporosis
10/08/2003EP0936903B1 Product with extender effect
10/08/2003EP0912211B1 Medical devices comprising ionically and non-ionically cross-linked polymer hydrogels having improved mechanical properties
10/08/2003EP0863742B1 Granular powders containing silicone oil
10/08/2003EP0814783B1 Multiple unit effervescent dosage forms comprising protonpump inhibitor
10/08/2003EP0773753B1 An implantable containment apparatus for a therapeutical device
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/08/2003CN1447704A Flow resistance modulated aerosolized active agent delivery
10/08/2003CN1447698A Flavone-contg. plant extract solutions having improved storage and head stability
10/08/2003CN1447694A Rapid onset formulation
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1447686A D-Enantiomer of DFMO and methods of use thereof for treating cancer
10/08/2003CN1447685A Process for decreasing cell proliferation based on (3R,4R)-Ôû�8-tetrahydrocannabinol)-11-acid
10/08/2003CN1447684A Stable gabapentin having PH within controlled range
10/08/2003CN1447683A Polymeric micelle compsns.
10/08/2003CN1447682A Amphotericin B structured emulsion
10/08/2003CN1447681A Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
10/08/2003CN1447680A Topical micronutrient delivery system and uses thereof
10/08/2003CN1446833A Warm sensitivity degradable micro gelatin and its preparation method
10/08/2003CN1446731A Method for packing decoction of granule pieces of Chinese herbal medicine
10/08/2003CN1446576A Adhibition film for acesodyne and apocatastasis caused by intramuscular injection
10/08/2003CN1446572A Granule of ÔÇÿJingangtengÔÇÖ for treating inflammatory gynecopathy and its preparation method
10/08/2003CN1446570A Externally applied agent for preventing infectious disease in respiratory tract as well as preparation method
10/08/2003CN1446563A Medical ointment for treating child cough with dyspnea and its preparation method
10/08/2003CN1446562A Quick dissolving sensitive layer for treating gynecopathy
10/08/2003CN1446540A Combination of semisolid framework preparation of progesterone
10/08/2003CN1446537A Freeze drying powder pins of methane-sulfonic acid dihydro elboline and its preparing method
10/08/2003CN1446535A Chlorhydric [R(2)-alpha-methoxyimindogen-alpha-(1-dicycloaza [2.2.2] caryl-3-group) acetonitrile control-released dosage form
10/08/2003CN1446534A Lipoidosis of Chinese herbal medicine alkaloid and its preparation
10/08/2003CN1446483A Technique for processing medlar fine powder
10/08/2003CN1123351C Externally applied liquid Chinese medicine for treating diarrhea
10/08/2003CN1123346C Animal cartilage health-care capsule for inhibiting tumour growth, eliminating free radical and anti peroxidation of lipid and prepn. method thereof
10/08/2003CN1123344C Slowly-released agent of piperazine ferulate
10/08/2003CN1123343C Nicotine compsns. and method for formulation thereof
10/08/2003CN1123338C Pharmaceutical formulation of omeprazole
10/08/2003CN1123337C Liquid aqueous pharmaceutical compsns. comprising sodium alginate and potassium bicarbonate
10/08/2003CN1123333C Process for encapsulation of caplets in capsule and solid dosage forms obtained by such process
10/08/2003CA2424751A1 Pharmaceutical compositions of acetylsalicylic acid and omega-3 oils
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003US6630486 Containing calcium sulfate
10/07/2003US6630477 Therapeutic nucleoside compound
10/07/2003US6630466 Anticholinergics which have a long-lasting effect, such as glycopyrronium bromide, tiotropium bromide or an ester of bi-or tricyclic amino alcohol such as a nortropanol
10/07/2003US6630459 Immunoisolation of a cell; use of biomedically pure, p-GlcNAc of high molecular weight and consistent properties.
10/07/2003US6630457 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
10/07/2003US6630455 Methods for inducing mucosal immune responses
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630171 Polypeptide polymers of aspartic acid and glutamic acid bearing a hydrophobic group; drug delivery; insulin carrier
10/07/2003US6630170 Mesoporous compositions and method of preparation
10/07/2003US6630169 Particulate delivery systems and methods of use
10/07/2003US6630168 Dimethylacetamide in combination with methyl cellulose, hydroxypropyl methylcellulose, or carboxypolymethylene; intralesional administering
10/07/2003US6630166 Coated tablet does not crack during storage; cellulose ether, sugar, calcium phosphate excipient
10/07/2003US6630165 For sustained release; therapy
10/07/2003US6630162 Pharmaceutical formulation and its use
10/07/2003US6630161 Stable oil in water emulsion; vaccine; squalene, PLURONIC, egg phosphatidyl choline, glycerol, alpha tocopherol
10/07/2003US6630156 Process for preparing biodegradable microspheres containing physiologically active agents
10/07/2003US6630155 Thermoplastic base polymer, a solvent, a poly(lactide-co-glycolide)/polyethylene glycol block polymer
10/07/2003US6630151 Addition of a long chain carboxylic acid thickener in cosmetics and pharmaceuticals;
10/07/2003US6630150 Microcrystalline cellulose, an oily substance, surfactant, and water; capsule or tablet solid dosage forms; oil in water emulsion
10/07/2003US6630149 Blister containing a transdermal therapeutic system and a single dose form of administration
10/07/2003US6630146 Candida albicans phosphomannan complex as a vaccine
10/07/2003US6630135 Improved method of sterilizing the field of surgery; corneal penetration enhancer
10/07/2003US6630129 Pharmaceutical formulation of fluticasone propionate
10/07/2003US6630121 Supercritical fluid-assisted nebulization and bubble drying
10/07/2003US6629970 Method of restoring endothelium of cornea
10/07/2003US6629968 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
1 ... 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 ... 2991